Lozol

Quick links to important sections

Lozol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lozol

Property Description
Active ingredient Indapamide
Form Oral tablet
Pharmacological class Thiazide-like diuretic; Antihypertensive agent
General purpose Lowering elevated blood pressure
Origin Synthetic, sulfonamide-derived

Lozol: Identity and Active Ingredient

Lozol is the brand name for an orally administered medication that contains the active ingredient Indapamide. This medication is provided as a standard oral tablet formulation and is classified as a prescription-only medication. Indapamide is chemically identified as a synthetic substance that belongs to the sulfonamide family, being a distinctive indole derivative. As a single-agent product, the medication's therapeutic effects are entirely attributed to the Indapamide component. It is clinically recognized for its efficacy and is frequently prescribed to adults needing consistent blood pressure control.

Pharmacological Class and General Purpose

Lozol is formally classified as an antihypertensive agent and a diuretic, specifically designated as a thiazide-like diuretic. The general purpose of Indapamide is to achieve sustained lowering of elevated blood pressure by reducing the mechanical strain on the cardiovascular system. The medication is utilized in managing high blood pressure. This medication is used for achieving blood pressure goals.

How Does Indapamide Differ from Thiazides?

Indapamide is designated as thiazide-like because its chemical structure is distinct from that of conventional thiazide diuretics. This difference grants Indapamide a crucial dual action mechanism. While it promotes the removal of excess salt and water by the kidneys (diuresis), it also exerts an independent vasodilatory effect, helping blood vessels relax and widen. Indapamide reduces peripheral vascular resistance. This indicates the medicine works not just by removing fluid, but also by relaxing the blood vessel walls. This combined physiological action provides a more comprehensive approach to managing arterial pressure.

Regulatory References

  1. NLM Drug Information

What side effects are possible with Lozol?

Possible Side Effects and Safety Information

The safety profile of Lozol (Indapamide) is based on classifications from governmental regulatory agencies, detailing adverse reactions by frequency and the body system affected. The medicine's risk profile is formally structured around common metabolic effects, specific system-organ classes, and rare but serious safety constraints.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their documented occurrence in clinical studies, with the frequency framework aligning with regulatory standards (e.g., EMA/ICH):

Frequency Category Associated Adverse Reactions (Examples)
Common Hypokalaemia (low potassium), Hypersensitivity reactions (primarily skin rash)
Uncommon Vomiting, Purpura, Hyponatraemia (low sodium)
Rare Vertigo, Paraesthesia, Dry mouth, Constipation, Thrombocytopenia
Very Rare Agranulocytosis, Haemolytic anaemia, Acute renal failure, Severe hypotension

Systemic Safety Considerations

The official labeling notes effects across several System-Organ Classes, including Metabolism and Nutrition Disorders (e.g., electrolyte imbalance), Nervous System Disorders (e.g., headache, dizziness), Gastrointestinal Disorders, and Blood and Lymphatic System Disorders (e.g., blood cell changes).

Serious adverse reactions, though very rare, include severe blood cell disorders like agranulocytosis and the potential for hepatic encephalopathy in individuals with pre-existing hepatic impairment. Certain effects, such as hypokalaemia, are identified as dose-related in regulatory documents.

Safety limitations restrict the use of Lozol, as it is contraindicated in cases of severe renal failure, severe hepatic impairment, and hypokalemia that is refractory to treatment. For special populations, specific warnings note the increased susceptibility of older adults to severe electrolyte imbalance and hypotension.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for Lozol (Indapamide) overdose indicates that symptoms are primarily related to the exaggerated effects of the medication, resulting in profound fluid and electrolyte loss. The official guidance is to seek immediate medical attention for any suspected overdose.

Documented Overdose Manifestations

System Manifestations Listed in Regulatory Labels
Cardiovascular Profound Hypotension (low blood pressure) and risk of Cardiac Rhythm Disturbances.
Metabolic Severe Electrolyte disturbances, including Hyponatremia (low sodium) and Hypokalemia (low potassium).
CNS / GI Dizziness, Somnolence (drowsiness), Nausea, and Vomiting.

Regulatory Emergency Actions

The most serious outcomes are associated with life-threatening electrolyte imbalances and severe hypotension. In susceptible patients with pre-existing liver conditions, overdose may precipitate Hepatic Coma.

Treatment for Lozol overdose is strictly symptomatic and supportive, as no specific antidote is known. The official procedure requires medical professionals to focus on correcting the fluid and electrolyte deficits, re-establishing plasma volume, and intensive monitoring of vital signs and cardiac function. Urgent medical care is mandatory to manage these severe physiological disturbances.

Therapeutic Uses of Lozol

What Lozol Treats: Main Uses and Benefits

Lozol (Indapamide) is generally used for the sustained reduction of elevated arterial pressure in adults with hypertension. The medication is used for managing chronic high blood pressure and may assist with maintaining functional stability over the long term. This therapeutic domain primarily covers the management of hypertension and is relevant for easing fluid retention (edema) associated with chronic heart conditions. This provides support that helps ease the overall symptom burden in conditions where symptoms create noticeable physiological strain. The medication is applied in clinical contexts where systemic fluid and salt retention causes symptomatic distress.


Relief from Fluid Retention and Swelling (Edema)

Lozol assists with addressing symptoms related to systemic imbalance, which directly provides relief from associated swelling or edema, a frequent manifestation of conditions presenting with systemic or localized discomfort, such as congestive heart failure.

“This approach provides supportive relief when symptoms interfere with routine activities and supports general well-being during symptomatic phases.”

Quick Fact: Applicable for Elevated Blood Pressure and Chronic Swelling

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Lozol (Indapamide) is generally approved for use in adults (18 years and older) for labeled conditions. Use in older adults is permitted but requires caution due to the greater frequency of reduced organ function. The safety and effectiveness of Lozol have not been established in pediatric patients (under 18 years old) and is not approved for this age group.


Populations Who Must Not Use Lozol (Contraindications)

Official regulatory labeling establishes absolute non-eligibility for several patient groups. Lozol is contraindicated for people who have a known Hypersensitivity (allergy) to indapamide or any sulfonamide-derived drugs.

Additionally, use is strictly prohibited in patients with pre-existing conditions that include:

  • Anuria (inability to urinate)
  • Severe Hepatic Impairment or Hepatic Encephalopathy
  • Hypokalaemia (abnormally low blood potassium levels)

Conditional and Restricted Eligibility

Use is contraindicated during Lactation (breastfeeding). During Pregnancy, routine use in otherwise healthy women is not appropriate; it is indicated only when edema is due to pathological causes.

Patients with Impaired Hepatic Function, Severe Renal Disease, Diabetes Mellitus, or Gout/Hyperuricemia may require specific monitoring and should use the medicine with caution, as detailed in the official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for Lozol (Indapamide) based on regulatory labeling, focusing on specific substance constraints.


Documented Interaction Patterns

Substance / Category Officially Documented Interaction Restrictions
Lithium Reduced renal clearance of Lithium, leading to increased plasma concentration and risk of toxicity. Use Not Recommended
Potassium-depleting Drugs Increased risk of hypokalemia (low potassium) due to an additive pharmacodynamic effect. Use with caution, requiring monitoring
Digitalis Preparations Hypokalemia/hypomagnesemia predisposes the patient to digitalis toxicity. Requires electrolyte monitoring
Non-steroidal Anti-inflammatory Drugs (NSAIDs) Potential decrease in antihypertensive/diuretic effect; risk of acute renal failure in dehydrated patients. Caution in use, especially if dehydrated
ACE Inhibitors Risk of profound hypotension; requires Indapamide discontinuation 3 days prior to initiating the ACE inhibitor for hypertension. Sequencing Rule Mandated
Torsades de Pointes ( TdP) Agents Explicit risk of TdP due to Indapamide-induced hypokalemia. Contraindicated (non-antiarrhythmic agents)

Additional Constraints

Co-administration with Alcohol is documented to result in an additive hypotensive effect. Indapamide's official interaction profile is characterized by pharmacodynamic effects on electrolytes and blood pressure, requiring strict adherence to sequencing rules when combining with certain antihypertensive agents.

Mechanism of Action

How Lozol Works: Mechanism of Action

Lozol (Indapamide) modulates physiological processes through a dual mechanism affecting the kidney and the vasculature. Its primary action is inhibition of the sodium ( Na^+) and chloride ( Cl^-) cotransporter (NCC) located in the distal convoluted tubules of the kidney. This blockade prevents the reabsorption of these ions and water back into the bloodstream. This inhibition initiates a diuretic cascade, resulting in decreased plasma and extracellular fluid volume, a change that modulates the fluid-volume component of arterial pressure regulation.

Simultaneously, Lozol exerts a secondary, non-diuretic effect by acting as a modulator of ion channels in vascular smooth muscle cells, leading to a reduction in the internal concentration of calcium ( Ca^2+). This mechanism facilitates the relaxation of the blood vessel walls, which reduces Total Peripheral Resistance (TPR).

A downstream consequence of the renal action is the alteration of electrolyte balance: the increased delivery of Na^+ to the collecting duct triggers a counter-exchange mechanism, resulting in a net loss of potassium ( K^+) and magnesium ( Mg^2+).

Dosage and Administration Information

How to Use Lozol: Official Administration Guidelines

The proper administration of Lozol (Indapamide) is defined by a structured, single daily regimen. The medication is for oral administration only, supplied as an immediate-release tablet.

Standard Dosage and Frequency

Lozol is taken once daily (q.d.). To help minimize the risk of nocturnal urination, administration is typically scheduled for the morning. The medication may be taken with or without food.

Clinical Scenario Initial Dosing Regimen (Oral) Dose Titration/Adjustment
Hypertension 1.25 mg once daily May be increased at 4-week intervals; maximum 5 mg daily
Edema/Fluid Retention 2.5 mg once daily Maximum dose typically 5 mg daily

Administration and Procedural Rules

The full tablet must be swallowed whole with water. For specific slow-release formulations, the tablets must not be crushed, cut, or chewed, as this alters the intended drug release pattern. The therapy is intended for use as a long-term management plan, as the full blood pressure reduction effect develops progressively and may require several months to reach its maximum.

Special Population and Handling

For older adults, dose selection is typically cautious, often starting at the lowest available strength (1.25 mg). Use in children is not established. If a dose is missed, it should be skipped if it is close to the time for the next scheduled dose, and the dose must not be doubled.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lozol (Indapamide)

Evidence for Use in Elevated Blood Pressure (Hypertension)

Research exploring the use of Indapamide for elevated blood pressure was evaluated in numerous randomized controlled trials (RCTs), including some conducted over extended periods. These studies were designed to evaluate outcomes related to physiological strain, including the frequency of major long-term health events, and to research examined changes in blood pressure measurements. Researchers monitored a range of serious health events, including the incidence of stroke, heart attack, cardiovascular death, and all-cause mortality over many years.

Much of the evidence regarding major long-term health outcomes comes from studies where Indapamide was used as a component of a combination treatment regimen, often alongside other blood pressure-lowering agents. Findings described patterns observed across these study groups, particularly concerning measured changes in both systolic and diastolic blood pressure readings. Research highlights changes measured during the study periods, which contribute to the broader evidence landscape for conditions characterized by functional limitations.

Evidence for Use in Fluid Retention (Edema)

The evidence base for Indapamide was studied for fluid retention (edema), often associated with conditions like chronic heart failure, and comes from clinical studies and smaller Randomized Controlled Trials. These studies were applied in research contexts involving fluctuating or unstable symptoms. Research monitored outcomes related to systemic or functional imbalance, such as changes in body weight and urine output, and observed how patients reported their experience with swelling. Studies reported measurements of how fluid levels evolved in the observed populations over defined, shorter time intervals.

What is Still Uncertain in the Research Record

While substantial evidence exists for the medicine's use, particularly in combination therapy for hypertension, several limitations and gaps remain in the research landscape. For instance, the data provide limited information about the long-term clinical outcomes when Indapamide was observed in a single-agent setting. Furthermore, subgroup findings are uncertain for specific, narrowly defined patient groups who were often excluded from the major, multi-year trials. Long-term effects are not fully established for the management of fluid retention, where study durations were often shorter.

Key Studies & References

  1. Indapamide: MedlinePlus Drug Information (Uses and Purpose)

Frequently Asked Questions (FAQ)

Common questions about Lozol (FAQ)

Q: Can Lozol cause dehydration?

According to the official prescribing information, the drug works by reducing the body's fluid volume. This process can lead to imbalances in fluids and electrolytes, which may include a reduction in circulating volume (hypovolemia). The changes associated with this reduction in fluid volume are documented in official safety information as possible effects of the medication.

Q: Are there any foods or drinks that should be avoided when taking Lozol?

Official drug information indicates that Lozol (Indapamide) has no documented interactions with specific foods or non-alcoholic beverages. The medication can be taken with or without food. Due to the drug’s action on electrolytes, balancing salt and fluid intake is a factor that may be discussed as part of the overall management plan.

Q: Does Lozol affect blood sugar levels?

Regulatory documents state that this medication can cause an increase in serum glucose levels, which is the sugar circulating in the blood. For individuals who have diabetes, official product information notes that the requirements for other diabetes medications may be altered.

Q: Is it normal to urinate more frequently when taking Lozol?

The medication is classified as a diuretic, and increased urination is a documented functional effect as the body removes excess fluid. Official sources note this increase is typically most pronounced when starting and may lessen after a few weeks of continuous use.

Q: What are the signs of a serious allergic reaction to Lozol?

Severe allergic (hypersensitivity) reactions are possible, although uncommon. Official regulatory warnings document symptoms such as swelling of the face, lips, tongue, or throat, as well as difficulty breathing or swallowing, as signs of a serious allergic reaction.

Q: Can Lozol interact with medications for diabetes?

Official prescribing information notes that a healthcare provider may need to consider adjustments to a patient's diabetes medication because this drug has the potential to raise blood sugar levels.

Q: Are there any long-term safety studies on Lozol?

Research reviewed by health authorities indicates that clinical trials have examined the use of Lozol over extended periods. These long-term studies generally describe the drug as being well tolerated and indicate that it does not typically create long-term biochemical abnormalities related to cardiovascular risk factors.

Q: How quickly does Lozol usually start working?

The onset of the medication's blood pressure-lowering action is described in clinical summaries as rapid, often beginning within 1 to 2 weeks of starting treatment. However, the medication is intended for long-term management, and the full, maximum effect on blood pressure may take several months (typically 3 to 4 months) to develop.

Q: Can Lozol cause skin sensitivity to the sun?

Official safety information documents that Lozol may cause an increased sensitivity of the skin to sunlight, a condition known as photosensitivity. Severe sunburn has been reported in regulatory side effect listings. Regulatory documents advise general awareness to avoid prolonged sun exposure.

Q: Do the side effects of Lozol usually go away over time?

Adverse effects documented for Lozol are officially described as mild and transient. Transient means the effect is short-lived and tends to pass away over time.

Q: Is Lozol known to affect sleep patterns?

Official side effect profiles list trouble sleeping or insomnia as one of the reported adverse reactions. It is categorized as a less common effect of the medication.

Q: How long does the effect of a single dose of Lozol last?

The official pharmacokinetic data describes the drug's elimination from the body, noting a terminal half-life of 14 to 24 hours. This pharmacological property is the basis for the medication's typical scheduling as a once-daily dose.

Q: Does taking Lozol affect driving or operating machinery?

Official warnings document that the medication may cause dizziness or drowsiness. For this reason, patients are cautioned to use care with activities that require full attention, such as driving or operating heavy machinery.

Q: Are there any lab tests required before starting Lozol?

Official monitoring guidelines specify that periodic determinations of serum electrolytes (like potassium), as well as uric acid and glucose levels, are relevant monitoring parameters during treatment.

Q: Does Lozol affect cholesterol levels?

Studies and official clinical reviews indicate that long-term use of the medication generally does not induce harmful effects on lipid metabolism, which includes cholesterol and triglyceride levels.

Q: Is Lozol a first-line treatment for high blood pressure?

Official treatment guidelines classify this medication as a thiazide-like diuretic. Based on research evidence, it is cited in guidelines as an agent considered for the initial management of high blood pressure (hypertension).

Q: Why does Lozol have a maximum recommended daily dose?

Regulatory documents establish a maximum recommended daily dose because increasing the dose beyond this point does not lead to a greater blood pressure-lowering effect. The official safety concern is that taking a higher dose significantly increases the risk of dose-related adverse effects, such as hypokalemia (low potassium).

Q: What is the purpose of the inactive ingredients in Lozol tablets?

Inactive ingredients are components of the tablet formulation that have no therapeutic effect. According to official labeling, these components provide the drug with its form, structure, stability, and coating.

Q: Does Lozol cause fatigue or tiredness?

Official side effect profiles list tiredness or fatigue as a reported adverse reaction. This effect is often associated with the potential for the medication to cause shifts in electrolyte balance.

Q: Is there a risk of withdrawal symptoms if Lozol is stopped suddenly?

Stopping the medication abruptly can potentially lead to withdrawal symptoms, including a sudden return of high blood pressure, known as rebound hypertension. Regulatory guidance cautions against discontinuing the use of this long-term medication without the specific instruction of a healthcare professional.

How should Lozol be stored and disposed of?

Official Storage and Disposal Requirements for Lozol

Storage of Lozol (Indapamide) is strictly governed by regulatory labeling to maintain product stability and safety. This medication must be stored at controlled room temperature, specifically between 20^circC and 25^circC (68^circF and 77^circF), with limited permissible excursions up to 30^circC.

Storage Constraint Requirement
Environmental Protection Keep away from excess heat, moisture, and direct light. Do not store in the bathroom.
Container Condition Keep the medicine in its original container, which must be kept tightly closed.
Child Safety Keep the medication out of the reach of children and securely locked in a safe location.

Disposal instructions mandate that medicine which is outdated or no longer needed must not be kept. Patients are directed to consult a healthcare professional for guidance on the proper and safe disposal methods for any unused product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lozol found in:

A-Z Index: